Research

Stem cell research.

Weekly reads: effective LDL gene editing, Chinese genetics guidelines, human embryo models in space

LDL gene editing

If you take a statin to improve your lipid profile, someday could you undergo LDL gene editing instead? Might that day be sooner than we think? A new paper has generated great interest in this topic including in the media. LDL gene editing For example, we have: One-and-Done Heart Disease Prevention? Scientists Show It May […]

Weekly reads: effective LDL gene editing, Chinese genetics guidelines, human embryo models in space Read More »

My favorite weird & not-so-weird but cool science pictures from 16 years of The Niche: Part 1

flesh-faced robots

I love science pictures. Even when I was a kid, images of science really struck me. I’ve been doing The Niche now for 16 years and come across many unusual pictures during that time. It’s hard to imagine that I started this site in 2010. What a different world that was. In some ways, it

My favorite weird & not-so-weird but cool science pictures from 16 years of The Niche: Part 1 Read More »

1st George Church retraction: BioViva Rutgers anti-aging paper with Liz Parrish

George-Church

A new Retraction Watch story on a George Church retraction caught my eye. It’s his first retraction out of reportedly more than seven hundred publications for him. Here’s the story: Genomics pioneer George Church earns first retraction for anti-aging gene therapy paper. I highly recommend the piece as it has a lot of detail. It

1st George Church retraction: BioViva Rutgers anti-aging paper with Liz Parrish Read More »

Weekly reads: MSCs, senescence, exosomes, primate aging, cancer stealing mitochondria

Mesenchymal-stem-cell-exosomes

I’m still waiting to see the first TV commercial on exosomes, umbilical cord cell injections for aging, or PRP. It’s got to be coming one of these days. Part of the problem is that I don’t really have time to watch TV most days. Maybe it’ll be an ad on the New York Times (NYT)

Weekly reads: MSCs, senescence, exosomes, primate aging, cancer stealing mitochondria Read More »

Weekly reads: pericytes, Nature says don’t rush stem cell OKs, microglia for Alzheimer’s, MYCN

Pericytes

What are pericytes? What about brain pericytes? How are they different than brain parasites? Pericytes on the brain Someone once asked me my favorite type of cell. As a cell biologist, I easily can’t pick just one. It’s like asking a parent to pick their favorite child. However, I will say that pericytes and microglia

Weekly reads: pericytes, Nature says don’t rush stem cell OKs, microglia for Alzheimer’s, MYCN Read More »

Weekly reads: woolly mice & pseudo-mammoths, eye repair good news, Mesoblast $1.5M price tag

woolly mice

Ever heard of woolly mice? I hadn’t either until recently. The story begins with de-extinction research. De-extinction can be both cool and arguably a colossal waste of research dollars. The specific effort to de-extinct woolly mammoths fits that dual classification. Woolly mice on the road back to mammoths? Let’s dig into this with some news:

Weekly reads: woolly mice & pseudo-mammoths, eye repair good news, Mesoblast $1.5M price tag Read More »

Weekly reads: CBER changes, Parkinson’s, 2-dad mice, NIH woes continue

dr. peter marks, cell therapy

I recently looked at the organizational chart at the FDA’s Center for Biologics Evaluation and Research or CBER. Why? I have been anticipating some possible big changes there with the new administration. After all, with HHS Secretary RFK Jr. having previously claimed that the FDA was suppressing various unproven things including at least two kinds

Weekly reads: CBER changes, Parkinson’s, 2-dad mice, NIH woes continue Read More »

Subscribe to Our Newsletter

Be the first to know about the latest developments in stem cell and regenerative medicine research.